Delivery Order SPE2DB22D2005-SPE2DB25FJHG4

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,223.77 firm-fixed-price delivery order is for the drug product LATUDA 40 MG TABLET 30S. The contract has an ultimate completion date of November 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award is for the delivery of LATUDA 40 MG TABLET 30S to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The $1,337.90 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 19, 2024 with a completion date of November 20, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,629.42, is for the supply of LATUDA 40 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through July 18, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award, with ID SPE2DB24D1021|SPE2DB25FETHQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,170.35, is a delivery order contract for the supply of LATUDA 40 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 21, 2025. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $2,222.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LATUDA 40 MG TABLET 30S, a pharmaceutical product, with a completion date of July 8, 2024. The contract is not designated as a set-aside and is a firm fixed-price contract type. AmerisourceBergen Drug Corp is the prime contractor, and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,615.54 firm-fixed-price delivery order is for the supply of LATUDA 80 MG TABLET 30S, a specialty medication. The contract has a period of performance through June 20, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award, SPE2DB22D2005|SPE2DB25FJGX2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,968.68 firm-fixed-price delivery order is for the supply of LATUDA 40 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of January 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV7UB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $110,191.99 firm fixed-price delivery order contract is for the supply of the pharmaceutical product Latuda 80 mg tablets. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,929.42 Firm Fixed Price delivery order is for the supply of LATUDA 120 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Latuda 40 mg tablets. The $19,603.20 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the company's parent organization, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJHG4
    Delivery Order

This federal contract award, with ID SPE2DB22D2005|SPE2DB25FJHG4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,249.65 firm fixed-price delivery order is for the supply of LATUDA 40 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of February 11, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that broader IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:35 AM